Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting.

Abstract

OBJECTIVE To assess the effects of antidiabetic drugs on the risk of heart failure in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS We conducted a retrospective cohort study with a newly diagnosed diabetes cohort of 25,690 patients registered in the U.K. General Practice Research Database, 1988-1999. We categorized person-time drug exposures to monotherapies in insulin, sulfonylureas (SUs), metformins, and other oral hypoglycemic agents (i.e., acarbose, guar gum) and combination therapy including insulin, combination therapy without insulin, and triple combination therapy with or without insulin. A drug-free time interval served as a reference category. Cox interval-wise (piece-wise) regression analyses were used. The main outcome was incident heart failure. RESULTS Among 43,390 drug exposure intervals for 25,690 patients who had a mean follow-up period of 2.5 years, 1,409 patients developed heart failure. Heart failure occurred most frequently in SU monotherapy exposure. After adjusting for duration of diabetes, the timing and order of treatments received, and known risk factors for heart failure, we found no differential effects among type-specific therapies. Patients with any drug use within the first year after diabetes diagnosis had a 4.75-fold higher risk (hazard ratio) for heart failure than those with drug-free status but had no increased risk during subsequent years. CONCLUSIONS In conclusion, the use of any pharmacological therapy for type 2 diabetes appears to be associated with an increased risk of heart failure. This risk does not persist beyond the first year after diagnosis of diabetes and does not appear to differ among the types of drug therapy examined. This observation suggests that the severity of diabetes or the preclinical duration of diabetes and the need for drug therapy, and not the therapy itself, is an explanation for heart failure in patients with type 2 diabetes.

3 Figures and Tables

05010015020072008200920102011201220132014201520162017
Citations per Year

322 Citations

Semantic Scholar estimates that this publication has 322 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Maru2005AntidiabeticDA, title={Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting.}, author={Shoko Maru and Gary G Koch and Monika Stender and Douglas Clark and Laura Gibowski and Hans Petri and Alice D White and Ross J Simpson}, journal={Diabetes care}, year={2005}, volume={28 1}, pages={20-6} }